Jenburkt Pharmaceuticals files disclosure with BSE Ltd. confirming compliance with SEBI circular on large corporate classification.
The company states it is not a large corporate for the financial year ended 31st March 2026 as per SEBI criteria.
Disclosure is made pursuant to SEBI circular SEBI/HO/DDHS/CIR/2021/613 dated 10th August 2021, updated on 13th April 2022.